Global Bicalutamide Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Bicalutamide is a non-steroidal antiandrogenic drug, which is used in combination with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy in the treatment of advanced prostate cancer.Bicalutamide first by oral absorption good.There is no pharmacodynamic or pharmacokinetic interaction with luteinizing hormone releasing hormone (LHRH) analogues.No interaction with common prescription drugs.No enzyme induction was observed at doses up to 150 mg per day.
LPI (LP Information)' newest research report, the “Bicalutamide Industry Forecast” looks at past sales and reviews total world Bicalutamide sales in 2022, providing a comprehensive analysis by region and market sector of projected Bicalutamide sales for 2023 through 2029. With Bicalutamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bicalutamide industry.
This Insight Report provides a comprehensive analysis of the global Bicalutamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bicalutamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bicalutamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bicalutamide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bicalutamide.
The global Bicalutamide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bicalutamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bicalutamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bicalutamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bicalutamide players cover AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals and Accel Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bicalutamide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Bicalutamide market?
What factors are driving Bicalutamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bicalutamide market opportunities vary by end market size?
How does Bicalutamide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Bicalutamide is a non-steroidal antiandrogenic drug, which is used in combination with luteinizing hormone releasing hormone (LHRH) analogues or surgical orchiectomy in the treatment of advanced prostate cancer.Bicalutamide first by oral absorption good.There is no pharmacodynamic or pharmacokinetic interaction with luteinizing hormone releasing hormone (LHRH) analogues.No interaction with common prescription drugs.No enzyme induction was observed at doses up to 150 mg per day.
LPI (LP Information)' newest research report, the “Bicalutamide Industry Forecast” looks at past sales and reviews total world Bicalutamide sales in 2022, providing a comprehensive analysis by region and market sector of projected Bicalutamide sales for 2023 through 2029. With Bicalutamide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bicalutamide industry.
This Insight Report provides a comprehensive analysis of the global Bicalutamide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bicalutamide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Bicalutamide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bicalutamide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bicalutamide.
The global Bicalutamide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Bicalutamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Bicalutamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Bicalutamide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Bicalutamide players cover AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals and Accel Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Bicalutamide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Tablets
- Capsule
- Single Drug For Prostate Cancer
- Combined Chemotherapy For Prostate Cancer
- Combined Radiation Therapy Or Castration For Prostate Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AstraZeneca
- CORDEN PHARMA GMBH
- Zeneca GmbH
- Actavis Pharma
- Sivem Pharmaceuticals
- Sorres Pharma
- Fresenius Kabi
- ANI Pharmaceuticals
- Accel Pharma
- Apotex Corporation
- Shanghai Fudan Fuhua Pharmaceutical
- Shanghai Zhaohui Pharmaceutical
- Zhejiang Haizheng Pharmaceutical
- Shanxi Zhendong Pharmaceutical
What is the 10-year outlook for the global Bicalutamide market?
What factors are driving Bicalutamide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bicalutamide market opportunities vary by end market size?
How does Bicalutamide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bicalutamide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bicalutamide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bicalutamide by Country/Region, 2018, 2022 & 2029
2.2 Bicalutamide Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.3 Bicalutamide Sales by Type
2.3.1 Global Bicalutamide Sales Market Share by Type (2018-2023)
2.3.2 Global Bicalutamide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bicalutamide Sale Price by Type (2018-2023)
2.4 Bicalutamide Segment by Application
2.4.1 Single Drug For Prostate Cancer
2.4.2 Combined Chemotherapy For Prostate Cancer
2.4.3 Combined Radiation Therapy Or Castration For Prostate Cancer
2.5 Bicalutamide Sales by Application
2.5.1 Global Bicalutamide Sale Market Share by Application (2018-2023)
2.5.2 Global Bicalutamide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bicalutamide Sale Price by Application (2018-2023)
3 GLOBAL BICALUTAMIDE BY COMPANY
3.1 Global Bicalutamide Breakdown Data by Company
3.1.1 Global Bicalutamide Annual Sales by Company (2018-2023)
3.1.2 Global Bicalutamide Sales Market Share by Company (2018-2023)
3.2 Global Bicalutamide Annual Revenue by Company (2018-2023)
3.2.1 Global Bicalutamide Revenue by Company (2018-2023)
3.2.2 Global Bicalutamide Revenue Market Share by Company (2018-2023)
3.3 Global Bicalutamide Sale Price by Company
3.4 Key Manufacturers Bicalutamide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bicalutamide Product Location Distribution
3.4.2 Players Bicalutamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BICALUTAMIDE BY GEOGRAPHIC REGION
4.1 World Historic Bicalutamide Market Size by Geographic Region (2018-2023)
4.1.1 Global Bicalutamide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bicalutamide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bicalutamide Market Size by Country/Region (2018-2023)
4.2.1 Global Bicalutamide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bicalutamide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bicalutamide Sales Growth
4.4 APAC Bicalutamide Sales Growth
4.5 Europe Bicalutamide Sales Growth
4.6 Middle East & Africa Bicalutamide Sales Growth
5 AMERICAS
5.1 Americas Bicalutamide Sales by Country
5.1.1 Americas Bicalutamide Sales by Country (2018-2023)
5.1.2 Americas Bicalutamide Revenue by Country (2018-2023)
5.2 Americas Bicalutamide Sales by Type
5.3 Americas Bicalutamide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bicalutamide Sales by Region
6.1.1 APAC Bicalutamide Sales by Region (2018-2023)
6.1.2 APAC Bicalutamide Revenue by Region (2018-2023)
6.2 APAC Bicalutamide Sales by Type
6.3 APAC Bicalutamide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bicalutamide by Country
7.1.1 Europe Bicalutamide Sales by Country (2018-2023)
7.1.2 Europe Bicalutamide Revenue by Country (2018-2023)
7.2 Europe Bicalutamide Sales by Type
7.3 Europe Bicalutamide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bicalutamide by Country
8.1.1 Middle East & Africa Bicalutamide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bicalutamide Revenue by Country (2018-2023)
8.2 Middle East & Africa Bicalutamide Sales by Type
8.3 Middle East & Africa Bicalutamide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bicalutamide
10.3 Manufacturing Process Analysis of Bicalutamide
10.4 Industry Chain Structure of Bicalutamide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bicalutamide Distributors
11.3 Bicalutamide Customer
12 WORLD FORECAST REVIEW FOR BICALUTAMIDE BY GEOGRAPHIC REGION
12.1 Global Bicalutamide Market Size Forecast by Region
12.1.1 Global Bicalutamide Forecast by Region (2024-2029)
12.1.2 Global Bicalutamide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bicalutamide Forecast by Type
12.7 Global Bicalutamide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Bicalutamide Product Portfolios and Specifications
13.1.3 AstraZeneca Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 CORDEN PHARMA GMBH
13.2.1 CORDEN PHARMA GMBH Company Information
13.2.2 CORDEN PHARMA GMBH Bicalutamide Product Portfolios and Specifications
13.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CORDEN PHARMA GMBH Main Business Overview
13.2.5 CORDEN PHARMA GMBH Latest Developments
13.3 Zeneca GmbH
13.3.1 Zeneca GmbH Company Information
13.3.2 Zeneca GmbH Bicalutamide Product Portfolios and Specifications
13.3.3 Zeneca GmbH Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zeneca GmbH Main Business Overview
13.3.5 Zeneca GmbH Latest Developments
13.4 Actavis Pharma
13.4.1 Actavis Pharma Company Information
13.4.2 Actavis Pharma Bicalutamide Product Portfolios and Specifications
13.4.3 Actavis Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Actavis Pharma Main Business Overview
13.4.5 Actavis Pharma Latest Developments
13.5 Sivem Pharmaceuticals
13.5.1 Sivem Pharmaceuticals Company Information
13.5.2 Sivem Pharmaceuticals Bicalutamide Product Portfolios and Specifications
13.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sivem Pharmaceuticals Main Business Overview
13.5.5 Sivem Pharmaceuticals Latest Developments
13.6 Sorres Pharma
13.6.1 Sorres Pharma Company Information
13.6.2 Sorres Pharma Bicalutamide Product Portfolios and Specifications
13.6.3 Sorres Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sorres Pharma Main Business Overview
13.6.5 Sorres Pharma Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Bicalutamide Product Portfolios and Specifications
13.7.3 Fresenius Kabi Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 ANI Pharmaceuticals
13.8.1 ANI Pharmaceuticals Company Information
13.8.2 ANI Pharmaceuticals Bicalutamide Product Portfolios and Specifications
13.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ANI Pharmaceuticals Main Business Overview
13.8.5 ANI Pharmaceuticals Latest Developments
13.9 Accel Pharma
13.9.1 Accel Pharma Company Information
13.9.2 Accel Pharma Bicalutamide Product Portfolios and Specifications
13.9.3 Accel Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Accel Pharma Main Business Overview
13.9.5 Accel Pharma Latest Developments
13.10 Apotex Corporation
13.10.1 Apotex Corporation Company Information
13.10.2 Apotex Corporation Bicalutamide Product Portfolios and Specifications
13.10.3 Apotex Corporation Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Apotex Corporation Main Business Overview
13.10.5 Apotex Corporation Latest Developments
13.11 Shanghai Fudan Fuhua Pharmaceutical
13.11.1 Shanghai Fudan Fuhua Pharmaceutical Company Information
13.11.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Fudan Fuhua Pharmaceutical Main Business Overview
13.11.5 Shanghai Fudan Fuhua Pharmaceutical Latest Developments
13.12 Shanghai Zhaohui Pharmaceutical
13.12.1 Shanghai Zhaohui Pharmaceutical Company Information
13.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.12.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.13 Zhejiang Haizheng Pharmaceutical
13.13.1 Zhejiang Haizheng Pharmaceutical Company Information
13.13.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Zhejiang Haizheng Pharmaceutical Main Business Overview
13.13.5 Zhejiang Haizheng Pharmaceutical Latest Developments
13.14 Shanxi Zhendong Pharmaceutical
13.14.1 Shanxi Zhendong Pharmaceutical Company Information
13.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanxi Zhendong Pharmaceutical Main Business Overview
13.14.5 Shanxi Zhendong Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Bicalutamide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Bicalutamide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Bicalutamide by Country/Region, 2018, 2022 & 2029
2.2 Bicalutamide Segment by Type
2.2.1 Tablets
2.2.2 Capsule
2.3 Bicalutamide Sales by Type
2.3.1 Global Bicalutamide Sales Market Share by Type (2018-2023)
2.3.2 Global Bicalutamide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Bicalutamide Sale Price by Type (2018-2023)
2.4 Bicalutamide Segment by Application
2.4.1 Single Drug For Prostate Cancer
2.4.2 Combined Chemotherapy For Prostate Cancer
2.4.3 Combined Radiation Therapy Or Castration For Prostate Cancer
2.5 Bicalutamide Sales by Application
2.5.1 Global Bicalutamide Sale Market Share by Application (2018-2023)
2.5.2 Global Bicalutamide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Bicalutamide Sale Price by Application (2018-2023)
3 GLOBAL BICALUTAMIDE BY COMPANY
3.1 Global Bicalutamide Breakdown Data by Company
3.1.1 Global Bicalutamide Annual Sales by Company (2018-2023)
3.1.2 Global Bicalutamide Sales Market Share by Company (2018-2023)
3.2 Global Bicalutamide Annual Revenue by Company (2018-2023)
3.2.1 Global Bicalutamide Revenue by Company (2018-2023)
3.2.2 Global Bicalutamide Revenue Market Share by Company (2018-2023)
3.3 Global Bicalutamide Sale Price by Company
3.4 Key Manufacturers Bicalutamide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bicalutamide Product Location Distribution
3.4.2 Players Bicalutamide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR BICALUTAMIDE BY GEOGRAPHIC REGION
4.1 World Historic Bicalutamide Market Size by Geographic Region (2018-2023)
4.1.1 Global Bicalutamide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Bicalutamide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Bicalutamide Market Size by Country/Region (2018-2023)
4.2.1 Global Bicalutamide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Bicalutamide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Bicalutamide Sales Growth
4.4 APAC Bicalutamide Sales Growth
4.5 Europe Bicalutamide Sales Growth
4.6 Middle East & Africa Bicalutamide Sales Growth
5 AMERICAS
5.1 Americas Bicalutamide Sales by Country
5.1.1 Americas Bicalutamide Sales by Country (2018-2023)
5.1.2 Americas Bicalutamide Revenue by Country (2018-2023)
5.2 Americas Bicalutamide Sales by Type
5.3 Americas Bicalutamide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bicalutamide Sales by Region
6.1.1 APAC Bicalutamide Sales by Region (2018-2023)
6.1.2 APAC Bicalutamide Revenue by Region (2018-2023)
6.2 APAC Bicalutamide Sales by Type
6.3 APAC Bicalutamide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Bicalutamide by Country
7.1.1 Europe Bicalutamide Sales by Country (2018-2023)
7.1.2 Europe Bicalutamide Revenue by Country (2018-2023)
7.2 Europe Bicalutamide Sales by Type
7.3 Europe Bicalutamide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Bicalutamide by Country
8.1.1 Middle East & Africa Bicalutamide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Bicalutamide Revenue by Country (2018-2023)
8.2 Middle East & Africa Bicalutamide Sales by Type
8.3 Middle East & Africa Bicalutamide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bicalutamide
10.3 Manufacturing Process Analysis of Bicalutamide
10.4 Industry Chain Structure of Bicalutamide
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bicalutamide Distributors
11.3 Bicalutamide Customer
12 WORLD FORECAST REVIEW FOR BICALUTAMIDE BY GEOGRAPHIC REGION
12.1 Global Bicalutamide Market Size Forecast by Region
12.1.1 Global Bicalutamide Forecast by Region (2024-2029)
12.1.2 Global Bicalutamide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bicalutamide Forecast by Type
12.7 Global Bicalutamide Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 AstraZeneca
13.1.1 AstraZeneca Company Information
13.1.2 AstraZeneca Bicalutamide Product Portfolios and Specifications
13.1.3 AstraZeneca Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 AstraZeneca Main Business Overview
13.1.5 AstraZeneca Latest Developments
13.2 CORDEN PHARMA GMBH
13.2.1 CORDEN PHARMA GMBH Company Information
13.2.2 CORDEN PHARMA GMBH Bicalutamide Product Portfolios and Specifications
13.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 CORDEN PHARMA GMBH Main Business Overview
13.2.5 CORDEN PHARMA GMBH Latest Developments
13.3 Zeneca GmbH
13.3.1 Zeneca GmbH Company Information
13.3.2 Zeneca GmbH Bicalutamide Product Portfolios and Specifications
13.3.3 Zeneca GmbH Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Zeneca GmbH Main Business Overview
13.3.5 Zeneca GmbH Latest Developments
13.4 Actavis Pharma
13.4.1 Actavis Pharma Company Information
13.4.2 Actavis Pharma Bicalutamide Product Portfolios and Specifications
13.4.3 Actavis Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Actavis Pharma Main Business Overview
13.4.5 Actavis Pharma Latest Developments
13.5 Sivem Pharmaceuticals
13.5.1 Sivem Pharmaceuticals Company Information
13.5.2 Sivem Pharmaceuticals Bicalutamide Product Portfolios and Specifications
13.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sivem Pharmaceuticals Main Business Overview
13.5.5 Sivem Pharmaceuticals Latest Developments
13.6 Sorres Pharma
13.6.1 Sorres Pharma Company Information
13.6.2 Sorres Pharma Bicalutamide Product Portfolios and Specifications
13.6.3 Sorres Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Sorres Pharma Main Business Overview
13.6.5 Sorres Pharma Latest Developments
13.7 Fresenius Kabi
13.7.1 Fresenius Kabi Company Information
13.7.2 Fresenius Kabi Bicalutamide Product Portfolios and Specifications
13.7.3 Fresenius Kabi Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius Kabi Main Business Overview
13.7.5 Fresenius Kabi Latest Developments
13.8 ANI Pharmaceuticals
13.8.1 ANI Pharmaceuticals Company Information
13.8.2 ANI Pharmaceuticals Bicalutamide Product Portfolios and Specifications
13.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ANI Pharmaceuticals Main Business Overview
13.8.5 ANI Pharmaceuticals Latest Developments
13.9 Accel Pharma
13.9.1 Accel Pharma Company Information
13.9.2 Accel Pharma Bicalutamide Product Portfolios and Specifications
13.9.3 Accel Pharma Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Accel Pharma Main Business Overview
13.9.5 Accel Pharma Latest Developments
13.10 Apotex Corporation
13.10.1 Apotex Corporation Company Information
13.10.2 Apotex Corporation Bicalutamide Product Portfolios and Specifications
13.10.3 Apotex Corporation Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Apotex Corporation Main Business Overview
13.10.5 Apotex Corporation Latest Developments
13.11 Shanghai Fudan Fuhua Pharmaceutical
13.11.1 Shanghai Fudan Fuhua Pharmaceutical Company Information
13.11.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shanghai Fudan Fuhua Pharmaceutical Main Business Overview
13.11.5 Shanghai Fudan Fuhua Pharmaceutical Latest Developments
13.12 Shanghai Zhaohui Pharmaceutical
13.12.1 Shanghai Zhaohui Pharmaceutical Company Information
13.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shanghai Zhaohui Pharmaceutical Main Business Overview
13.12.5 Shanghai Zhaohui Pharmaceutical Latest Developments
13.13 Zhejiang Haizheng Pharmaceutical
13.13.1 Zhejiang Haizheng Pharmaceutical Company Information
13.13.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Zhejiang Haizheng Pharmaceutical Main Business Overview
13.13.5 Zhejiang Haizheng Pharmaceutical Latest Developments
13.14 Shanxi Zhendong Pharmaceutical
13.14.1 Shanxi Zhendong Pharmaceutical Company Information
13.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolios and Specifications
13.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanxi Zhendong Pharmaceutical Main Business Overview
13.14.5 Shanxi Zhendong Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Bicalutamide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bicalutamide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsule
Table 5. Global Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 6. Global Bicalutamide Sales Market Share by Type (2018-2023)
Table 7. Global Bicalutamide Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bicalutamide Revenue Market Share by Type (2018-2023)
Table 9. Global Bicalutamide Sale Price by Type (2018-2023) & (US$/Pcs)
Table 10. Global Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 11. Global Bicalutamide Sales Market Share by Application (2018-2023)
Table 12. Global Bicalutamide Revenue by Application (2018-2023)
Table 13. Global Bicalutamide Revenue Market Share by Application (2018-2023)
Table 14. Global Bicalutamide Sale Price by Application (2018-2023) & (US$/Pcs)
Table 15. Global Bicalutamide Sales by Company (2018-2023) & (M Pcs)
Table 16. Global Bicalutamide Sales Market Share by Company (2018-2023)
Table 17. Global Bicalutamide Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bicalutamide Revenue Market Share by Company (2018-2023)
Table 19. Global Bicalutamide Sale Price by Company (2018-2023) & (US$/Pcs)
Table 20. Key Manufacturers Bicalutamide Producing Area Distribution and Sales Area
Table 21. Players Bicalutamide Products Offered
Table 22. Bicalutamide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bicalutamide Sales by Geographic Region (2018-2023) & (M Pcs)
Table 26. Global Bicalutamide Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bicalutamide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bicalutamide Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bicalutamide Sales by Country/Region (2018-2023) & (M Pcs)
Table 30. Global Bicalutamide Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bicalutamide Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bicalutamide Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bicalutamide Sales by Country (2018-2023) & (M Pcs)
Table 34. Americas Bicalutamide Sales Market Share by Country (2018-2023)
Table 35. Americas Bicalutamide Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bicalutamide Revenue Market Share by Country (2018-2023)
Table 37. Americas Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 38. Americas Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 39. APAC Bicalutamide Sales by Region (2018-2023) & (M Pcs)
Table 40. APAC Bicalutamide Sales Market Share by Region (2018-2023)
Table 41. APAC Bicalutamide Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bicalutamide Revenue Market Share by Region (2018-2023)
Table 43. APAC Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 44. APAC Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 45. Europe Bicalutamide Sales by Country (2018-2023) & (M Pcs)
Table 46. Europe Bicalutamide Sales Market Share by Country (2018-2023)
Table 47. Europe Bicalutamide Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bicalutamide Revenue Market Share by Country (2018-2023)
Table 49. Europe Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 50. Europe Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 51. Middle East & Africa Bicalutamide Sales by Country (2018-2023) & (M Pcs)
Table 52. Middle East & Africa Bicalutamide Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bicalutamide Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bicalutamide Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 56. Middle East & Africa Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Bicalutamide
Table 58. Key Market Challenges & Risks of Bicalutamide
Table 59. Key Industry Trends of Bicalutamide
Table 60. Bicalutamide Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bicalutamide Distributors List
Table 63. Bicalutamide Customer List
Table 64. Global Bicalutamide Sales Forecast by Region (2024-2029) & (M Pcs)
Table 65. Global Bicalutamide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bicalutamide Sales Forecast by Country (2024-2029) & (M Pcs)
Table 67. Americas Bicalutamide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bicalutamide Sales Forecast by Region (2024-2029) & (M Pcs)
Table 69. APAC Bicalutamide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bicalutamide Sales Forecast by Country (2024-2029) & (M Pcs)
Table 71. Europe Bicalutamide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bicalutamide Sales Forecast by Country (2024-2029) & (M Pcs)
Table 73. Middle East & Africa Bicalutamide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bicalutamide Sales Forecast by Type (2024-2029) & (M Pcs)
Table 75. Global Bicalutamide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bicalutamide Sales Forecast by Application (2024-2029) & (M Pcs)
Table 77. Global Bicalutamide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AstraZeneca Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Bicalutamide Product Portfolios and Specifications
Table 80. AstraZeneca Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. CORDEN PHARMA GMBH Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 84. CORDEN PHARMA GMBH Bicalutamide Product Portfolios and Specifications
Table 85. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 86. CORDEN PHARMA GMBH Main Business
Table 87. CORDEN PHARMA GMBH Latest Developments
Table 88. Zeneca GmbH Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 89. Zeneca GmbH Bicalutamide Product Portfolios and Specifications
Table 90. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 91. Zeneca GmbH Main Business
Table 92. Zeneca GmbH Latest Developments
Table 93. Actavis Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 94. Actavis Pharma Bicalutamide Product Portfolios and Specifications
Table 95. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 96. Actavis Pharma Main Business
Table 97. Actavis Pharma Latest Developments
Table 98. Sivem Pharmaceuticals Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 99. Sivem Pharmaceuticals Bicalutamide Product Portfolios and Specifications
Table 100. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 101. Sivem Pharmaceuticals Main Business
Table 102. Sivem Pharmaceuticals Latest Developments
Table 103. Sorres Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 104. Sorres Pharma Bicalutamide Product Portfolios and Specifications
Table 105. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 106. Sorres Pharma Main Business
Table 107. Sorres Pharma Latest Developments
Table 108. Fresenius Kabi Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius Kabi Bicalutamide Product Portfolios and Specifications
Table 110. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 111. Fresenius Kabi Main Business
Table 112. Fresenius Kabi Latest Developments
Table 113. ANI Pharmaceuticals Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 114. ANI Pharmaceuticals Bicalutamide Product Portfolios and Specifications
Table 115. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 116. ANI Pharmaceuticals Main Business
Table 117. ANI Pharmaceuticals Latest Developments
Table 118. Accel Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 119. Accel Pharma Bicalutamide Product Portfolios and Specifications
Table 120. Accel Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 121. Accel Pharma Main Business
Table 122. Accel Pharma Latest Developments
Table 123. Apotex Corporation Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Corporation Bicalutamide Product Portfolios and Specifications
Table 125. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 126. Apotex Corporation Main Business
Table 127. Apotex Corporation Latest Developments
Table 128. Shanghai Fudan Fuhua Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 130. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 131. Shanghai Fudan Fuhua Pharmaceutical Main Business
Table 132. Shanghai Fudan Fuhua Pharmaceutical Latest Developments
Table 133. Shanghai Zhaohui Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 134. Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 135. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 136. Shanghai Zhaohui Pharmaceutical Main Business
Table 137. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 138. Zhejiang Haizheng Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 140. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 141. Zhejiang Haizheng Pharmaceutical Main Business
Table 142. Zhejiang Haizheng Pharmaceutical Latest Developments
Table 143. Shanxi Zhendong Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 144. Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 145. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 146. Shanxi Zhendong Pharmaceutical Main Business
Table 147. Shanxi Zhendong Pharmaceutical Latest Developments
Table 1. Bicalutamide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Bicalutamide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsule
Table 5. Global Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 6. Global Bicalutamide Sales Market Share by Type (2018-2023)
Table 7. Global Bicalutamide Revenue by Type (2018-2023) & ($ million)
Table 8. Global Bicalutamide Revenue Market Share by Type (2018-2023)
Table 9. Global Bicalutamide Sale Price by Type (2018-2023) & (US$/Pcs)
Table 10. Global Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 11. Global Bicalutamide Sales Market Share by Application (2018-2023)
Table 12. Global Bicalutamide Revenue by Application (2018-2023)
Table 13. Global Bicalutamide Revenue Market Share by Application (2018-2023)
Table 14. Global Bicalutamide Sale Price by Application (2018-2023) & (US$/Pcs)
Table 15. Global Bicalutamide Sales by Company (2018-2023) & (M Pcs)
Table 16. Global Bicalutamide Sales Market Share by Company (2018-2023)
Table 17. Global Bicalutamide Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Bicalutamide Revenue Market Share by Company (2018-2023)
Table 19. Global Bicalutamide Sale Price by Company (2018-2023) & (US$/Pcs)
Table 20. Key Manufacturers Bicalutamide Producing Area Distribution and Sales Area
Table 21. Players Bicalutamide Products Offered
Table 22. Bicalutamide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Bicalutamide Sales by Geographic Region (2018-2023) & (M Pcs)
Table 26. Global Bicalutamide Sales Market Share Geographic Region (2018-2023)
Table 27. Global Bicalutamide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Bicalutamide Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Bicalutamide Sales by Country/Region (2018-2023) & (M Pcs)
Table 30. Global Bicalutamide Sales Market Share by Country/Region (2018-2023)
Table 31. Global Bicalutamide Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Bicalutamide Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Bicalutamide Sales by Country (2018-2023) & (M Pcs)
Table 34. Americas Bicalutamide Sales Market Share by Country (2018-2023)
Table 35. Americas Bicalutamide Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Bicalutamide Revenue Market Share by Country (2018-2023)
Table 37. Americas Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 38. Americas Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 39. APAC Bicalutamide Sales by Region (2018-2023) & (M Pcs)
Table 40. APAC Bicalutamide Sales Market Share by Region (2018-2023)
Table 41. APAC Bicalutamide Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Bicalutamide Revenue Market Share by Region (2018-2023)
Table 43. APAC Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 44. APAC Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 45. Europe Bicalutamide Sales by Country (2018-2023) & (M Pcs)
Table 46. Europe Bicalutamide Sales Market Share by Country (2018-2023)
Table 47. Europe Bicalutamide Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Bicalutamide Revenue Market Share by Country (2018-2023)
Table 49. Europe Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 50. Europe Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 51. Middle East & Africa Bicalutamide Sales by Country (2018-2023) & (M Pcs)
Table 52. Middle East & Africa Bicalutamide Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Bicalutamide Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Bicalutamide Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Bicalutamide Sales by Type (2018-2023) & (M Pcs)
Table 56. Middle East & Africa Bicalutamide Sales by Application (2018-2023) & (M Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Bicalutamide
Table 58. Key Market Challenges & Risks of Bicalutamide
Table 59. Key Industry Trends of Bicalutamide
Table 60. Bicalutamide Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Bicalutamide Distributors List
Table 63. Bicalutamide Customer List
Table 64. Global Bicalutamide Sales Forecast by Region (2024-2029) & (M Pcs)
Table 65. Global Bicalutamide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Bicalutamide Sales Forecast by Country (2024-2029) & (M Pcs)
Table 67. Americas Bicalutamide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Bicalutamide Sales Forecast by Region (2024-2029) & (M Pcs)
Table 69. APAC Bicalutamide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Bicalutamide Sales Forecast by Country (2024-2029) & (M Pcs)
Table 71. Europe Bicalutamide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Bicalutamide Sales Forecast by Country (2024-2029) & (M Pcs)
Table 73. Middle East & Africa Bicalutamide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Bicalutamide Sales Forecast by Type (2024-2029) & (M Pcs)
Table 75. Global Bicalutamide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Bicalutamide Sales Forecast by Application (2024-2029) & (M Pcs)
Table 77. Global Bicalutamide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. AstraZeneca Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 79. AstraZeneca Bicalutamide Product Portfolios and Specifications
Table 80. AstraZeneca Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 81. AstraZeneca Main Business
Table 82. AstraZeneca Latest Developments
Table 83. CORDEN PHARMA GMBH Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 84. CORDEN PHARMA GMBH Bicalutamide Product Portfolios and Specifications
Table 85. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 86. CORDEN PHARMA GMBH Main Business
Table 87. CORDEN PHARMA GMBH Latest Developments
Table 88. Zeneca GmbH Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 89. Zeneca GmbH Bicalutamide Product Portfolios and Specifications
Table 90. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 91. Zeneca GmbH Main Business
Table 92. Zeneca GmbH Latest Developments
Table 93. Actavis Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 94. Actavis Pharma Bicalutamide Product Portfolios and Specifications
Table 95. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 96. Actavis Pharma Main Business
Table 97. Actavis Pharma Latest Developments
Table 98. Sivem Pharmaceuticals Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 99. Sivem Pharmaceuticals Bicalutamide Product Portfolios and Specifications
Table 100. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 101. Sivem Pharmaceuticals Main Business
Table 102. Sivem Pharmaceuticals Latest Developments
Table 103. Sorres Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 104. Sorres Pharma Bicalutamide Product Portfolios and Specifications
Table 105. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 106. Sorres Pharma Main Business
Table 107. Sorres Pharma Latest Developments
Table 108. Fresenius Kabi Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius Kabi Bicalutamide Product Portfolios and Specifications
Table 110. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 111. Fresenius Kabi Main Business
Table 112. Fresenius Kabi Latest Developments
Table 113. ANI Pharmaceuticals Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 114. ANI Pharmaceuticals Bicalutamide Product Portfolios and Specifications
Table 115. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 116. ANI Pharmaceuticals Main Business
Table 117. ANI Pharmaceuticals Latest Developments
Table 118. Accel Pharma Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 119. Accel Pharma Bicalutamide Product Portfolios and Specifications
Table 120. Accel Pharma Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 121. Accel Pharma Main Business
Table 122. Accel Pharma Latest Developments
Table 123. Apotex Corporation Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 124. Apotex Corporation Bicalutamide Product Portfolios and Specifications
Table 125. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 126. Apotex Corporation Main Business
Table 127. Apotex Corporation Latest Developments
Table 128. Shanghai Fudan Fuhua Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 129. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 130. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 131. Shanghai Fudan Fuhua Pharmaceutical Main Business
Table 132. Shanghai Fudan Fuhua Pharmaceutical Latest Developments
Table 133. Shanghai Zhaohui Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 134. Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 135. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 136. Shanghai Zhaohui Pharmaceutical Main Business
Table 137. Shanghai Zhaohui Pharmaceutical Latest Developments
Table 138. Zhejiang Haizheng Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 139. Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 140. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 141. Zhejiang Haizheng Pharmaceutical Main Business
Table 142. Zhejiang Haizheng Pharmaceutical Latest Developments
Table 143. Shanxi Zhendong Pharmaceutical Basic Information, Bicalutamide Manufacturing Base, Sales Area and Its Competitors
Table 144. Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolios and Specifications
Table 145. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2018-2023)
Table 146. Shanxi Zhendong Pharmaceutical Main Business
Table 147. Shanxi Zhendong Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Bicalutamide
Figure 2. Bicalutamide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bicalutamide Sales Growth Rate 2018-2029 (M Pcs)
Figure 7. Global Bicalutamide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bicalutamide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsule
Figure 11. Global Bicalutamide Sales Market Share by Type in 2022
Figure 12. Global Bicalutamide Revenue Market Share by Type (2018-2023)
Figure 13. Bicalutamide Consumed in Single Drug For Prostate Cancer
Figure 14. Global Bicalutamide Market: Single Drug For Prostate Cancer (2018-2023) & (M Pcs)
Figure 15. Bicalutamide Consumed in Combined Chemotherapy For Prostate Cancer
Figure 16. Global Bicalutamide Market: Combined Chemotherapy For Prostate Cancer (2018-2023) & (M Pcs)
Figure 17. Bicalutamide Consumed in Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 18. Global Bicalutamide Market: Combined Radiation Therapy Or Castration For Prostate Cancer (2018-2023) & (M Pcs)
Figure 19. Global Bicalutamide Sales Market Share by Application (2022)
Figure 20. Global Bicalutamide Revenue Market Share by Application in 2022
Figure 21. Bicalutamide Sales Market by Company in 2022 (M Pcs)
Figure 22. Global Bicalutamide Sales Market Share by Company in 2022
Figure 23. Bicalutamide Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Bicalutamide Revenue Market Share by Company in 2022
Figure 25. Global Bicalutamide Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Bicalutamide Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Bicalutamide Sales 2018-2023 (M Pcs)
Figure 28. Americas Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 29. APAC Bicalutamide Sales 2018-2023 (M Pcs)
Figure 30. APAC Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 31. Europe Bicalutamide Sales 2018-2023 (M Pcs)
Figure 32. Europe Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Bicalutamide Sales 2018-2023 (M Pcs)
Figure 34. Middle East & Africa Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 35. Americas Bicalutamide Sales Market Share by Country in 2022
Figure 36. Americas Bicalutamide Revenue Market Share by Country in 2022
Figure 37. Americas Bicalutamide Sales Market Share by Type (2018-2023)
Figure 38. Americas Bicalutamide Sales Market Share by Application (2018-2023)
Figure 39. United States Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Bicalutamide Sales Market Share by Region in 2022
Figure 44. APAC Bicalutamide Revenue Market Share by Regions in 2022
Figure 45. APAC Bicalutamide Sales Market Share by Type (2018-2023)
Figure 46. APAC Bicalutamide Sales Market Share by Application (2018-2023)
Figure 47. China Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Bicalutamide Sales Market Share by Country in 2022
Figure 55. Europe Bicalutamide Revenue Market Share by Country in 2022
Figure 56. Europe Bicalutamide Sales Market Share by Type (2018-2023)
Figure 57. Europe Bicalutamide Sales Market Share by Application (2018-2023)
Figure 58. Germany Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Bicalutamide Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Bicalutamide Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Bicalutamide Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Bicalutamide Sales Market Share by Application (2018-2023)
Figure 67. Egypt Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Bicalutamide in 2022
Figure 73. Manufacturing Process Analysis of Bicalutamide
Figure 74. Industry Chain Structure of Bicalutamide
Figure 75. Channels of Distribution
Figure 76. Global Bicalutamide Sales Market Forecast by Region (2024-2029)
Figure 77. Global Bicalutamide Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Bicalutamide Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Bicalutamide Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Bicalutamide Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Bicalutamide Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Bicalutamide
Figure 2. Bicalutamide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bicalutamide Sales Growth Rate 2018-2029 (M Pcs)
Figure 7. Global Bicalutamide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Bicalutamide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsule
Figure 11. Global Bicalutamide Sales Market Share by Type in 2022
Figure 12. Global Bicalutamide Revenue Market Share by Type (2018-2023)
Figure 13. Bicalutamide Consumed in Single Drug For Prostate Cancer
Figure 14. Global Bicalutamide Market: Single Drug For Prostate Cancer (2018-2023) & (M Pcs)
Figure 15. Bicalutamide Consumed in Combined Chemotherapy For Prostate Cancer
Figure 16. Global Bicalutamide Market: Combined Chemotherapy For Prostate Cancer (2018-2023) & (M Pcs)
Figure 17. Bicalutamide Consumed in Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 18. Global Bicalutamide Market: Combined Radiation Therapy Or Castration For Prostate Cancer (2018-2023) & (M Pcs)
Figure 19. Global Bicalutamide Sales Market Share by Application (2022)
Figure 20. Global Bicalutamide Revenue Market Share by Application in 2022
Figure 21. Bicalutamide Sales Market by Company in 2022 (M Pcs)
Figure 22. Global Bicalutamide Sales Market Share by Company in 2022
Figure 23. Bicalutamide Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Bicalutamide Revenue Market Share by Company in 2022
Figure 25. Global Bicalutamide Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Bicalutamide Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Bicalutamide Sales 2018-2023 (M Pcs)
Figure 28. Americas Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 29. APAC Bicalutamide Sales 2018-2023 (M Pcs)
Figure 30. APAC Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 31. Europe Bicalutamide Sales 2018-2023 (M Pcs)
Figure 32. Europe Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Bicalutamide Sales 2018-2023 (M Pcs)
Figure 34. Middle East & Africa Bicalutamide Revenue 2018-2023 ($ Millions)
Figure 35. Americas Bicalutamide Sales Market Share by Country in 2022
Figure 36. Americas Bicalutamide Revenue Market Share by Country in 2022
Figure 37. Americas Bicalutamide Sales Market Share by Type (2018-2023)
Figure 38. Americas Bicalutamide Sales Market Share by Application (2018-2023)
Figure 39. United States Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Bicalutamide Sales Market Share by Region in 2022
Figure 44. APAC Bicalutamide Revenue Market Share by Regions in 2022
Figure 45. APAC Bicalutamide Sales Market Share by Type (2018-2023)
Figure 46. APAC Bicalutamide Sales Market Share by Application (2018-2023)
Figure 47. China Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Bicalutamide Sales Market Share by Country in 2022
Figure 55. Europe Bicalutamide Revenue Market Share by Country in 2022
Figure 56. Europe Bicalutamide Sales Market Share by Type (2018-2023)
Figure 57. Europe Bicalutamide Sales Market Share by Application (2018-2023)
Figure 58. Germany Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Bicalutamide Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Bicalutamide Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Bicalutamide Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Bicalutamide Sales Market Share by Application (2018-2023)
Figure 67. Egypt Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Bicalutamide Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Bicalutamide in 2022
Figure 73. Manufacturing Process Analysis of Bicalutamide
Figure 74. Industry Chain Structure of Bicalutamide
Figure 75. Channels of Distribution
Figure 76. Global Bicalutamide Sales Market Forecast by Region (2024-2029)
Figure 77. Global Bicalutamide Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Bicalutamide Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Bicalutamide Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Bicalutamide Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Bicalutamide Revenue Market Share Forecast by Application (2024-2029)
